Rephonic
Artwork for JTO Insights

JTO Insights

JTO Insights
Lung Cancer
Immunotherapy
Stage I Non-Small Cell Lung Cancer
Pulmonology
Advocacy Organizations
Trastuzumab Derastuzine
Lung Cancer Screening
Thoracic Surgery
Circulating Tumor DNA
Low-Dose CT Lung Cancer Screening
Journal Of Thoracic Oncology
KRAS G12C
Destiny Lung 03
Non-Small Cell Lung Cancer
Cardio-Oncology
Liquid Biopsy
Immune Signature Classifier
Bronchoscopy
TTF1
Interventional Radiology

Welcome to JTO Insights, the official podcast of the International Association for the Study of Lung Cancer (IASLC) Journal of Thoracic Oncology (JTO). In each episode, hosts Dr. Alex Adjei and Dr. Tom John deliver concise, accessible insights from the latest JTO research. Each episode features expert discussions with authors, highlighting key studies, clinical implications, and future directions ... more

PublishesTwice monthlyEpisodes14Founded7 months ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for JTO Insights

Latest Episodes

Episode 13: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the October issue of the Journal of Thoracic Oncology. Sai Yendamuri, MD, MBA, FACS, Director of t... more

In this episode of JTO Insights, recorded at the 2026 World Conference on Lung Cancer, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Kare... more

Episode 11: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host authors of two articles published in the September issue of the Journal of Thoracic Oncology. Shun Lu, MD, PhD, Associate editor for th... more

Episode Summary Episode 10: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Jean-Louis Pujol, Professor at... more

Episode 9: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John speak with authors of two articles published in the August issue of the Journal of Thoracic Oncology. Michael J. Grant, MD, Assistant Profess... more

Episode Summary Episode 8: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John highlight two articles published in the JTO 20th Anniversary Series. Dr. David Ryan of Royal Brompton & Harefield Hospitals, ... more

Episode 7: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host Dr. Masahiro Torasawa, the corresponding author of "Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector C... more

Episode 6: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host the corresponding author of an article published in the JTO 20th Anniversary Series. Dr. Emily Stone, a Conjoint Professor at the UNSW S... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
The Daily
The DailyThe New York Times

Recent Guests

Ahidetoshi Hayashi
Corresponding author; Professor, Department of Medical Oncology, Kanda University Faculty of Medicine, Osaka
Kanda University Faculty of Medicine, Osaka, Japan
Episode: JTO Insights: October 2026
Shunlu Lu
Director of Oncology; Professor, Shanghai Chest Hospital; Chief and Professor, Shanghai Lung Cancer Center
Shanghai Chest Hospital / Shanghai Lung Cancer Center
Episode: JTO Insights: October 2026
Karen Reckamp
Professor of Medicine and Director of the Division of Medical Oncology
Cedars-Sinai Medical Center; Samuel Oschin Comprehensive Cancer Institute
Episode: JTO Insights: 20 Years of Progress in Immunotherapy
Jean-Louis Pujol
Professor at Montpellier School of Medicine, Montpellier University
Montpellier University, France
Episode: JTO Insights: 20 Years of Progress in Patient Advocacy
Michael Grant
Corresponding author; Assistant Professor of Medicine, Medical Oncology, Yale University
Yale University School of Medicine
Episode: JTO Insights: August 2026
Christian Rolfo
Professor of Internal Medicine; Director of the Division of Medical Oncology
Ohio State University James Comprehensive Cancer Center
Episode: JTO Insights: August 2026
David Ryan
Physician from the Department of Radiology, Royal Brompton & Harefield Hospitals
Royal Brompton & Harefield Hospitals, London
Episode: JTO Insights: 20 Years of Advances in Imaging and Interventional Radiology
Masahiro Torasawa
Corresponding author of the case report; Assistant Professor, Department of Respiratory Medicine, John Tendo University School of Medicine, Tokyo, Japan
John Tendo University School of Medicine, Tokyo
Episode: JTO Insights: July 2026
Dr. Emily Stone
Conjoined professor, UNSW; consultant respiratory physician; head of the Department of Thoracic Medicine and Lung Transplantation at St Vincent's Hospital, Sydney; board chair of the Thoracic Oncology Group of Australasia
University of New South Wales / St Vincent's Hospital, Sydney
Episode: JTO Insights: 20 Years of Advances in Pulmonology

Hosts

Dr. Alex Adjei
Host of JTO Insights, Editor-in-Chief of JTO
Dr. Tom John
Co-host of JTO Insights

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
Radiolab
RadiolabWNYC Studios
Big Ideas Lab
Big Ideas LabMission.org
Bite Back with Abbey Sharp
Bite Back with Abbey SharpThe Roost Podcast Network
Science Friday
Science FridayScience Friday and WNYC Studios

Talking Points

Recent interactions between the hosts and their guests.

JTO Insights: 20 Years of Progress in Immunotherapy
Q: From your perspective, how has immunotherapy changed the treatment paradigm for lung cancer compared with chemotherapy and targeted therapy?
Immunotherapy has transformed outcomes for many patients, converting what was once short survival into years of survival for some, and extending potential cures into earlier-stage disease beyond what chemotherapy or targeted therapies could achieve alone.
JTO Insights: September 2026
Q: In the Skyscraper 02C study, what biomarker signals were associated with better outcomes for TIGIT-targeted therapy, and how should this influence future trials?
Correlative biomarker analyses suggested that PD-L1 positive tumors and inflamed subtypes showed numerical OS trends with tirgorolumab plus atezolizumab and chemotherapy, but these findings are exploratory and hypothesis-generating, guiding future biomarker-driven trials rather than immediate practice changes.
JTO Insights: September 2026
Q: Given the data on MET amplification detected by liquid biopsy, how reliable is MET amplification as a resistance marker, and how should clinicians interpret these results in real-world practice?
MET amplification was defined with a plasma copy number above a Garden 360 threshold of 2.2, with high specificity but variable sensitivity depending on tumor DNA shedding. The data suggest relative differences between arms are informative even if individual measurements may miss some events; clinicians should consider this as one piece of the resistance puzzle.
JTO Insights: September 2026
Q: The first article compares amivantamab–lasertinib versus osimertinib in first-line, with a focus on resistance mechanisms. How do the authors interpret the observation that many patients have unknown resistance, and what does this imply for clinical practice?
The authors acknowledge that unknown resistance was the majority in both arms, which means resistance biology cannot be fully captured by known alterations. They argue that this supports prevention strategies—targeting multiple pathways upfront—to reduce the likelihood of resistance evolving, rather than relying solely on sequencing after progression.
JTO Insights: 20 Years of Progress in Patient Advocacy
Q: What should be the top global priority over the next five years to make lung cancer care more equitable and patient-centered?
Prioritize equity by expanding access and support in low- and middle income countries, enhancing technical assistance, and strengthening international coalition efforts to destigmatize and improve care.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About JTO Insights

What is JTO Insights about and what kind of topics does it cover?

Listeners are likely clinicians, researchers, and healthcare professionals who follow thoracic oncology research and its practical applications. The show concentrates on immunotherapy, targeted therapies, biomarker-driven treatment, imaging and interventional radiology, and the evolving role of surgery and screening in lung cancer. Episodes often feature authors or subject-matter experts discussing major JTO studies, translational insights, and real-world implications for patient care, with a steady emphasis on biomarkers, resistance mechanisms, and multidisciplinary decision making. A notable strength is the ability to translate dense research into concise, clinically relevant takeaways and to spotlight regional trial data, novel therapies... more

Where can I find podcast stats for JTO Insights?

Rephonic provides a wide range of podcast stats for JTO Insights. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to JTO Insights and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does JTO Insights get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for JTO Insights, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for JTO Insights?

Rephonic provides comprehensive predictive audience data for JTO Insights, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does JTO Insights have?

To see how many followers or subscribers JTO Insights has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to JTO Insights?

These podcasts share a similar audience with JTO Insights:

1. Lung Cancer Considered
2. ASCO Daily News
3. Journal of Clinical Oncology (JCO) Podcast
4. Oncology Brothers: Practice-Changing Cancer Discussions
5. The Daily

How many episodes of JTO Insights are there?

JTO Insights launched 7 months ago and published 14 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact JTO Insights?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for JTO Insights?

Rephonic pulls ratings and reviews for JTO Insights from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for JTO Insights?

Rephonic provides full transcripts for episodes of JTO Insights. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on JTO Insights?

Recent guests on JTO Insights include:

1. Ahidetoshi Hayashi
2. Shunlu Lu
3. Karen Reckamp
4. Jean-Louis Pujol
5. Michael Grant
6. Christian Rolfo
7. David Ryan
8. Masahiro Torasawa

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days